Adriano Aguzzi, professor and director of the Institute of Neuropathology at the University of Zurich, has been awarded for his research into neurodegenerative diseases linked to aberrant protein aggregates, such as Alzheimer’s, Parkinson’s or Creutzfeldt-Jakob […]
Synapsis Foundation – Alzheimer Research Switzerland ARS announces a competition for Research Grants and Career Development Awards. Deadline for submission of proposals is 31 July 2018. The goal of the Synapsis Foundation is to support […]
ETH Zurich is a partner in the European EIT Health Consortium. For 2018, three new projects with ETH participation will receive funding by the Consortium. In one of these projects, an innovation project led by […]
Alzheimer’s Disease, stroke and depression are among the most serious brain diseases. Lifestyle choices play an important role in their etiology. The new book by Hans-Ruedi Olpe and his daughter Cora Olpe addresses risk factors […]
With the rapidly progressing development of therapies for Alzheimer’s Disease (AD) treatment, comes the need for sensitive diagnostics. Within the Oxford-McGill-ZNZ Partnership, the groups of Dr. med. Luka Kulic, of the University of Zurich and […]
Professor Lawrence Rajendran receives the SCOR Young Researcher European Grand Prize for his innovative research on Alzheimer’s disease (AD). Rajendran of the Systems and Cell Biology of Neurodegeneration, Institute for Regenerative Medicine (IREM), University of […]
BACE1, the enzyme involved in amyloid formation, is an important therapeutic target for Alzheimer’s Disease. Blocking BACE1 has, however, led to severe side effects. Professor Lawrence Rajendran and colleagues have now shown a method to […]
Dr. Maria Teresa Ferretti was awarded a three-year research grant from the Synapsis foundation to study the role of the immune system in Alzheimer’s disease. Together with co-applicants Dr. Luka Kulic and Prof. Britta Engelhardt […]
Copyright ©2023 Neuroscience Center Zurich | Web Design by catta